Impact of VACTERL Association and Chromosomal Anomalies on Outcomes After Esophageal Atresia Repair: Insights from the EUPSA Registry

Abstract

Objective

Although VACTERL association is a recognized entity in patients with esophageal atresia (EA), its impact on surgical outcomes remains unclear. This study aimed to evaluate the influence of VACTERL association and chromosomal anomalies (VACTERL-CA) on the surgical outcomes of EA patients, offering novel insights into risk stratification.

Methods

All patients enrolled in the European Pediatric Surgeons' Association (EUPSA) Esophageal Atresia Registry (EAR) between July 2014 and December 2017 were included. Patients were classified into two groups: those with VACTERL-CA and those without these anomalies (non-VACTERL). Groups were compared for demographics, associated malformations, surgical approach, complications, and outcomes.

Results

Among 372 patients, 22% (n = 82) were classified as VACTERL-CA. This group had significantly lower gestational age (35.9 weeks vs. 37.1 weeks, p = 0.004), birth weight (2,312 g vs. 2,663 g, p < 0.001), and APGAR scores at 5 and 10 minutes (p = 0.005). Surgical strategies, including rates of primary anastomosis (88% in both groups), did not differ. Anastomotic leak and stricture rates were similar; however, recurrent fistula was more common in VACTERL-CA (4.9% vs. 1.0%, p = 0.023). Overall mortality was higher in VACTERL-CA (14.6% vs. 5.2%, p = 0.003), largely due to associated anomalies such as cardiac or neurologic conditions, whereas EA-related mortality was more frequent in non-VACTERL (1% vs. 0%). Sepsis was also more frequent in VACTERL-CA (10.9% vs. 4.5%, p = 0.033). In multivariate analysis, low birth weight (adjusted odds ratios [aOR]: 0.95 per 100 g, p = 0.010) and cardiac malformations (aOR: 2.33, p = 0.002) were independently associated with VACTERL-CA.

Conclusion

EA patients with VACTERL-CA represent a high-risk subgroup characterized by prematurity, major cardiac defects, and increased sepsis risk. These findings highlight the need for early cardiac screening, standardized infection-prevention bundles, and tailored multidisciplinary care to improve survival and reduce preventable complications.

Keywords

esophageal atresia - VACTERL - chromosomal anomalies - outcome - tracheoesophageal fistula

• References

• 1 Quan L, Smith DW. The VATER association. Vertebral defects, anal atresia, T-E fistula with esophageal atresia, radial and renal dysplasia: a spectrum of associated defects. J Pediatr 1973; 82 (01) 104-107
• 2 Solomon BD. VACTERL/VATER association. Orphanet J Rare Dis 2011; 6: 56
• 3 Guptha S, Shumate C, Scheuerle AE. Likelihood of meeting defined VATER/VACTERL phenotype in infants with esophageal atresia with or without tracheoesophageal fistula. Am J Med Genet A 2019; 179 (11) 2202-2206
• 4 Galarreta CI, Vaida F, Bird LM. Patterns of malformation associated with esophageal atresia/tracheoesophageal fistula: a retrospective single center study. Am J Med Genet A 2020; 182 (06) 1351-1363
• 5 Allred ET, Perens EA, Coufal NG, Sanford Kobayashi E, Kingsmore SF, Dimmock DP. Genomic sequencing has a high diagnostic yield in children with congenital anomalies of the heart and urinary system. Front Pediatr 2023; 11: 1157630
• 6 Ritter J, Lisec K, Klinner M. et al. Genetic disruption of cilia-associated signaling pathways in patients with VACTERL association. Children (Basel) 2023; 10 (05) 882
• 7 Ćomić J, Tilch E, Riedhammer KM. et al. Trio Exome Sequencing in VACTERL Association. Kidney Int Rep 2024; 10 (03) 877-891
• 8 Tan Tanny SP, Beck C, King SK. et al. Survival trends and syndromic esophageal atresia. Pediatrics 2021; 147 (05) e2020029884
• 9 Evanovich DM, Wang JT, Zendejas B, Jennings RW, Bajic D. From the ground up: esophageal atresia types, disease severity stratification and survival rates at a single institution. Front Surg 2022; 9: 799052
• 10 Lazow SP, Ben-Ishay O, Aribindi VK. et al. Predictors of index admission mortality and morbidity in contemporary esophageal atresia patients. J Pediatr Surg 2020; 55 (11) 2322-2328
• 11 Nishi E, Takamizawa S, Iio K. et al. Surgical intervention for esophageal atresia in patients with trisomy 18. Am J Med Genet A 2014; 164A [phone]
• 12 Hew NLC, Grover Z, Paida S. et al. Predictors of poor outcomes in children with tracheoesophageal fistula/oesophageal atresia: an Australian experience. World J Pediatr Surg 2021; 4 (02) e000190
• 13 Rayyan M, Embrechts M, Van Veer H. et al. Neonatal factors predictive for respiratory and gastro-intestinal morbidity after esophageal atresia repair. Pediatr Neonatol 2019; 60 (03) 261-269
• 14 Morini F, Conforti A, Zani A. et al. Diagnostic workup of neonates with esophageal atresia: results from the EUPSA Esophageal Atresia Registry. Front Pediatr 2020; 8: 489
• 15 Okamoto T, Takamizawa S, Arai H. et al. Esophageal atresia: prognostic classification revisited. Surgery 2009; 145 (06) 675-681
• 16 Keefe G, Culbreath K, Edwards EM. et al. Current outcomes of infants with esophageal atresia and tracheoesophageal fistula: a multicenter analysis. J Pediatr Surg 2022; 57 (06) 970-974
• 17 Quiroz HJ, Turpin A, Willobee BA. et al. Nationwide analysis of mortality and hospital readmissions in esophageal atresia. J Pediatr Surg 2020; 55 (05) 824-829
• 18 Hunt RW, Perkins EJ, King S. Peri-operative management of neonates with oesophageal atresia and tracheo-oesophageal fistula. Paediatr Respir Rev 2016; 19: 3-9
• 19 Almong A, Zani A. Postoperative complications and long-term outcomes of tracheoesophageal fistula repair. Curr Chall Thorac Surg 2022; 4: 30
• 20 Tandon RK, Sharma S, Sinha SK. et al. Esophageal atresia: factors influencing survival - experience at an Indian tertiary centre. J Indian Assoc Pediatr Surg 2008; 13 (01) 2-6
• 21 Kassa AM, Lilja HE. Neurodevelopmental outcomes in individuals with VACTERL association. A population-based cohort study. PLoS One 2023; 18 (06) e0288061